Shaolin Capital Management’s Agriculture & Natural Solutions Acquisition Corp ANSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.73M Buy
238,750
+38,750
+19% +$440K 0.13% 157
2026
Q1
$2.26M Buy
200,000
+100,000
+100% +$1.12M 0.08% 186
2025
Q4
$1.12M Sell
100,000
-300,000
-75% -$3.33M 0.03% 209
2025
Q3
$4.36M Sell
400,000
-117
-0% -$1.27K 0.19% 75
2025
Q2
$4.34M Buy
+400,117
New +$4.29M 0.15% 57
2024
Q3
Sell
-200,000
Closed -$2.05M 272
2024
Q2
$2.05M Sell
200,000
-300,000
-60% -$3.07M 0.06% 96
2024
Q1
$5.08M Buy
+500,000
New +$5.07M 0.06% 57

Other funds holding ANSC

Shaolin Capital Management's ANSC Position: Q2 2026 in Review

Shaolin Capital Management increased its Agriculture & Natural Solutions Acquisition Corp (ANSC) stake by 19% in Q2 2026, buying an estimated $440K and bringing the position to 238,750 shares worth $2.73M. The position accounts for 0.13% of the portfolio, ranked #157.

Shaolin Capital Management first reported a position in ANSC in Q1 2024 and has held it in 7 quarters since. The position peaked at $5.08M in Q1 2024. 43 funds tracked by Wall St. Rank hold ANSC as of Q2 2026.

  • Shaolin Capital Management held 238,750 shares of Agriculture & Natural Solutions Acquisition Corp worth $2.73M as of Q2 2026.
  • Shaolin Capital Management bought 38,750 Agriculture & Natural Solutions Acquisition Corp shares in Q2 2026, an estimated $440K.
  • Agriculture & Natural Solutions Acquisition Corp made up 0.13% of Shaolin Capital Management's portfolio in Q2 2026, its #157 holding.
  • Shaolin Capital Management first reported a position in Agriculture & Natural Solutions Acquisition Corp in Q1 2024 and has held it in 7 quarters since.
  • Shaolin Capital Management's Agriculture & Natural Solutions Acquisition Corp position peaked at $5.08M in Q1 2024.
  • 43 funds tracked by Wall St. Rank held Agriculture & Natural Solutions Acquisition Corp as of Q2 2026.

Based on Shaolin Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.